Vrisha Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 08-07-2024
- Paid Up Capital ₹ 0.10 M
as on 08-07-2024
- Company Age 19 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.96 Cr
as on 08-07-2024
- Satisfied Charges ₹ 3.67 Cr
as on 08-07-2024
- Revenue 497.14%
(FY 2022)
- Profit 79.36%
(FY 2022)
- Ebitda 195.65%
(FY 2022)
- Net Worth -3.58%
(FY 2022)
- Total Assets -18.81%
(FY 2022)
About Vrisha Pharmaceuticals
The Corporate was formerly known as Vrisha Pharmaceticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.96 Cr. The company has closed loans amounting to ₹3.67 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sajid Asfi, Rajendra Apandkar, and Jagdish Chaudhari serve as directors at the Company.
- CIN/LLPIN
U52310MH2005PTC156801
- Company No.
156801
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Oct 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Navi Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Vrisha Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajendra Apandkar  | Director | 13-Dec-2017 | Current |
| Sajid Asfi | Director | 20-May-2018 | Current |
| Jagdish Chaudhari | Additional Director | 17-Dec-2021 | Current |
Financial Performance of Vrisha Pharmaceuticals.
Vrisha Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 497.14% increase. The company also saw a substantial improvement in profitability, with a 79.36% increase in profit. The company's net worth dipped by a decrease of 3.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vrisha Pharmaceuticals?
Unlock access to Vrisha Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Megaaplex Prime Propertes LlpInactive For E-Filing 1 year 10 months
Jagdish Chaudhari is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 22 Jul 2016 | ₹2.01 Cr | Open |
Axis Bank Limited Creation Date: 21 Feb 2011 | ₹9.50 M | Open |
Icici Bank Limited Creation Date: 23 Sep 2013 | ₹1.77 Cr | Satisfied |
How Many Employees Work at Vrisha Pharmaceuticals?
Unlock and access historical data on people associated with Vrisha Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vrisha Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vrisha Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
